LASTACAFT

This brand name is authorized in Brazil, Ecuador, Mexico, Singapore, Turkey, United States

Active ingredients

The drug LASTACAFT contains one active pharmaceutical ingredient (API):

1 Alcaftadine UNII 7Z8O94ECSX - ALCAFTADINE

Alcaftadine is an H1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated. Read about Alcaftadine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LASTACAFT Solution (Drops)	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01GX11		S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501012030011902
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1605-MEE-1215
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 141M2013
Country: SG	Health Sciences Authority	Identifier(s): 14297P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699490561300
Country: US	FDA, National Drug Code	Identifier(s): 0023-4290